Novel hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

Details for Australian Patent Application No. 2006220500 (hide)

Owner Board of Regents, The University of Texas System

Inventors Fang, Bingliang; Roth, Jack A.; Ji, Linx.

Agent Pizzeys

Pub. Number AU-A-2006220500

PCT Pub. Number WO2006/096815

Priority 60/659,935 09.03.05 US

Filing date 9 March 2006

Wipo publication date 14 September 2006

International Classifications

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/096815 Priority application(s): WO2006/096815

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220501-Human leptin-derived polypeptides and uses thereof

2006220489-System and method for trustworthy metering and deactivation